Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SGC-CK2-1 is an inhibitor of casein kinase 2α (CK2α; IC50s = 4.2 and 2.3 nM for the catalytic subunits CK2α and CK2α’, respectively).1 It is selective for CK2α over DYRK2, Plk4, MEK5, and HIPK1, -2, and -3 (IC50s = 440, >10,000, 1,000, 3,700, 3,400, and 8,100 nM, respectively). SGC-CK2-1 (0.01-10 µM) decreases phosphorylation of Akt in HCT116 cells. See the Structural Genomics Consortium (SGC) website for more information.
WARNING This product is not for human or veterinary use.
1. Development of a potent and selective chemical probe for the pleiotropic kinase CK2. Cell Chem. Biol. 28(4), 546-558 (2021).